In a panel session moderated by John Doyle of Quintiles and Kenneth Getz of the Center for the Study of Drug Development at Tufts University, Mark Augustine of Augustine Investment Advisors, Dr. Andreas Koester of Janssen R&D, Jeffrey Kraut of North Shore LIJ and Dr. Gregory Steinberg of Aetna explored the alternatives to “going it alone” when developing safe and effective new medicines and more sustainable approaches to healthcare delivery. This panel examined the key factors driving increased collaboration, barriers to success and a wide range of new collaborative models among the various “ecosystem” players, including among competitors.

Click the links below to view the entire panel session.
Chapter 1: Collaboration Drivers and Trends (length: 7:58)
Chapter 2: Barriers to Successful Collaboration (length: 4:35)
Chapter 3: Future Visions (length: 5:51)